ARTHROPLASTY
0.1% ropivacaine equivalent to 0.2% ropivacaine for lumbar plexus infusion following THA
This report has been verified
by one or more authors of the
original publication.
Pain Med. 2014 Mar;15(3):465-72. doi: 10.1111/pme.12309
30 patients undergoing elective primary THA were randomized to receive either 0.1% or 0.2% ropivacaine for lumbar plexus infusion, to compare postoperative opioid consumption between these concentrations. No significant differences were observed between groups with respect to postoperative opioid consumption, function, pain, patient satisfaction, and hospital stay. Results suggest that 0.1% ropivacaine provides similar postoperative analgesia to 0.2% ropivacaine.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
